At Ashford Biotech, a few board members had arrived early for the meeting and were chatting casually around the conference table.
“Did you guys see the latest market report? A small startup just beat us to it. Their imaging algorithm runs twice as fast and is two percent more accurate than ours.”
“You mean Medi AI? I’ve been keeping an eye on them since last year. They’re using artificial intelligence in diagnostics—reading medical scans faster and more precisely than any existing system. It’s a total game changer.”
That immediately caught the others’ attention. “Yeah, I’ve heard a few doctors talking about them too. But does anyone actually know who owns that company?”
They all looked around at each other and shook their heads.
Weird. A company that type would need serious funding—pr
